ACCESSION: MSBNK-SMB_Measured-HSA001P0214023
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 135
COMMENT: RAW_SPEC {'BLK01_7139': {'bp': 996518.0, 'sum': 3881838.0}, '10_posi_7853': {'bp': 482045.0, 'sum': 1893410.0}, '13_posi_7746': {'bp': 547417.0, 'sum': 2112594.0}, '14_posi_7703': {'bp': 565462.0, 'sum': 2233298.0}, '16_posi_7515': {'bp': 598230.0, 'sum': 2299578.0}, '12_posi_7304': {'bp': 614847.0, 'sum': 2348739.0}, '16_posi_7725': {'bp': 663235.0, 'sum': 2752650.0}, '11_posi_7095': {'bp': 673441.0, 'sum': 2482148.0}, '15_posi_7244': {'bp': 681601.0, 'sum': 2581575.0}, '10_posi_7284': {'bp': 685512.0, 'sum': 2520459.0}, '7_posi_7054': {'bp': 700812.0, 'sum': 2551270.0}, '3_posi_7013': {'bp': 710028.0, 'sum': 2571078.0}, '7_posi_7411': {'bp': 720877.0, 'sum': 2587683.0}, '17_posi_7474': {'bp': 723868.0, 'sum': 2702323.0}, '12_posi_7012': {'bp': 728641.0, 'sum': 2717548.0}, '2_posi_7537': {'bp': 818207.0, 'sum': 2972970.0}, '19_posi_7850': {'bp': 602010.0, 'sum': 2392023.0}, '8_posi_7769': {'bp': 631463.0, 'sum': 2422728.0}, '9_posi_7832': {'bp': 637103.0, 'sum': 2406170.0}, '12_posi_7559': {'bp': 660841.0, 'sum': 2467554.0}, '16_posi_7160': {'bp': 666130.0, 'sum': 2518945.0}, '18_posi_7685': {'bp': 707670.0, 'sum': 2743952.0}, '16_posi_7851': {'bp': 508103.0, 'sum': 2049560.0}, '6_posi_7811': {'bp': 552685.0, 'sum': 2200319.0}, '14_posi_7788': {'bp': 574888.0, 'sum': 2271078.0}, '4_posi_7559': {'bp': 586242.0, 'sum': 2313838.0}, '3_posi_7788': {'bp': 716374.0, 'sum': 2794623.0}, '14_posi_7117': {'bp': 747286.0, 'sum': 2733006.0}, '11_posi_7578': {'bp': 558075.0, 'sum': 2175366.0}, '17_posi_7685': {'bp': 583835.0, 'sum': 2213313.0}, '11_posi_7368': {'bp': 647600.0, 'sum': 2431959.0}, '10_posi_7411': {'bp': 664293.0, 'sum': 2624399.0}, '16_posi_7073': {'bp': 708505.0, 'sum': 2624356.0}, '15_posi_7326': {'bp': 738353.0, 'sum': 2813022.0}, '10_posi_7118': {'bp': 764787.0, 'sum': 2856646.0}, '8_posi_7853': {'bp': 562686.0, 'sum': 2249219.0}, '10_posi_7201': {'bp': 664129.0, 'sum': 2519183.0}, '15_posi_7578': {'bp': 696729.0, 'sum': 2740262.0}, '19_posi_7388': {'bp': 710490.0, 'sum': 2704336.0}, '1_posi_7096': {'bp': 671479.0, 'sum': 2410494.0}, '14_posi_7391': {'bp': 690001.0, 'sum': 2680950.0}, 'BLK01_7664': {'bp': 877112.0, 'sum': 3375497.0}, '3_posi_7097': {'bp': 695060.0, 'sum': 2482772.0}, '12_posi_7641': {'bp': 687963.0, 'sum': 2666580.0}, '3_posi_7243': {'bp': 669856.0, 'sum': 2516284.0}, '1_posi_6992': {'bp': 662841.0, 'sum': 2382724.0}, '16_posi_7601': {'bp': 633072.0, 'sum': 2411728.0}, '9_posi_7370': {'bp': 631711.0, 'sum': 2387360.0}, '5_posi_7853': {'bp': 627044.0, 'sum': 2406838.0}, '1_posi_7391': {'bp': 600214.0, 'sum': 2254637.0}, '17_posi_7306': {'bp': 588952.0, 'sum': 2329658.0}, 'BLK01_7538': {'bp': 821229.0, 'sum': 3088884.0}, '10_posi_7643': {'bp': 759130.0, 'sum': 2945211.0}, '10_posi_7747': {'bp': 751437.0, 'sum': 2785969.0}, '11_posi_7181': {'bp': 727879.0, 'sum': 2679502.0}, '11_posi_7009': {'bp': 711347.0, 'sum': 2639041.0}, '6_posi_6987': {'bp': 674919.0, 'sum': 2629434.0}, '6_posi_7600': {'bp': 660711.0, 'sum': 2440316.0}, '17_posi_7117': {'bp': 658751.0, 'sum': 2427991.0}, '15_posi_7494': {'bp': 652926.0, 'sum': 2543547.0}, '19_posi_7768': {'bp': 651614.0, 'sum': 2540015.0}, '2_posi_7746': {'bp': 641966.0, 'sum': 2399226.0}, '12_posi_7851': {'bp': 627440.0, 'sum': 2447422.0}, 'BLK02_7286': {'bp': 609994.0, 'sum': 2237948.0}, 'BLK01_7242': {'bp': 943040.0, 'sum': 3652500.0}, '16_posi_6990': {'bp': 826983.0, 'sum': 3097471.0}, '2_posi_7180': {'bp': 790149.0, 'sum': 2832557.0}, '12_posi_7223': {'bp': 786346.0, 'sum': 2937865.0}, '18_posi_7160': {'bp': 768440.0, 'sum': 2985649.0}, '2_posi_7093': {'bp': 757952.0, 'sum': 2858946.0}, '3_posi_7366': {'bp': 743632.0, 'sum': 2819799.0}, '8_posi_7095': {'bp': 709785.0, 'sum': 2593230.0}, '14_posi_7265': {'bp': 671218.0, 'sum': 2730947.0}, '5_posi_7303': {'bp': 666227.0, 'sum': 2409465.0}, '12_posi_7747': {'bp': 633618.0, 'sum': 2401035.0}, '15_posi_7136': {'bp': 633098.0, 'sum': 2379740.0}, '10_posi_7535': {'bp': 611856.0, 'sum': 2253448.0}, '8_posi_7412': {'bp': 592804.0, 'sum': 2203574.0}, '17_posi_7811': {'bp': 591940.0, 'sum': 2309333.0}, '9_posi_7474': {'bp': 590602.0, 'sum': 2288339.0}, 'ProcedureBlank_7748': {'bp': 582882.0, 'sum': 2139280.0}, '11_posi_7454': {'bp': 570105.0, 'sum': 2256203.0}, '19_posi_7031': {'bp': 740068.0, 'sum': 2867490.0}, '5_posi_7538': {'bp': 690532.0, 'sum': 2549878.0}, '13_posi_7454': {'bp': 689892.0, 'sum': 2634590.0}, '12_posi_7474': {'bp': 671027.0, 'sum': 2525075.0}, '19_posi_7202': {'bp': 668867.0, 'sum': 2540479.0}, '17_posi_7201': {'bp': 666128.0, 'sum': 2511929.0}, 'ProcedureBlank_7160': {'bp': 663195.0, 'sum': 2429365.0}, '8_posi_7202': {'bp': 661437.0, 'sum': 2579421.0}, '18_posi_7305': {'bp': 655270.0, 'sum': 2449417.0}, '9_posi_7137': {'bp': 642931.0, 'sum': 2354388.0}, '16_posi_7348': {'bp': 618557.0, 'sum': 2406928.0}, '18_posi_7769': {'bp': 591837.0, 'sum': 2385795.0}, '19_posi_7599': {'bp': 584662.0, 'sum': 2336519.0}, '13_posi_7285': {'bp': 691740.0, 'sum': 2667636.0}, '14_posi_7012': {'bp': 685653.0, 'sum': 2561197.0}, '6_posi_7391': {'bp': 679355.0, 'sum': 2527522.0}, '17_posi_7557': {'bp': 677839.0, 'sum': 2655052.0}, 'BLK02_7853': {'bp': 653139.0, 'sum': 2479460.0}, '7_posi_7495': {'bp': 641511.0, 'sum': 2409544.0}, '5_posi_7684': {'bp': 632453.0, 'sum': 2473857.0}, '13_posi_7137': {'bp': 613074.0, 'sum': 2309218.0}, '1_posi_7601': {'bp': 584716.0, 'sum': 2197624.0}, 'BLK02_7663': {'bp': 556504.0, 'sum': 2077638.0}, '2_posi_7370': {'bp': 734750.0, 'sum': 2659981.0}, '4_posi_6992': {'bp': 714532.0, 'sum': 2576239.0}, 'ProcedureBlank_7261': {'bp': 698916.0, 'sum': 2455685.0}, '7_posi_7326': {'bp': 673221.0, 'sum': 2508555.0}, '3_posi_7454': {'bp': 623034.0, 'sum': 2304246.0}, '8_posi_7537': {'bp': 618992.0, 'sum': 2364646.0}, '7_posi_7180': {'bp': 719097.0, 'sum': 2667720.0}, '9_posi_7263': {'bp': 682950.0, 'sum': 2626419.0}, '6_posi_7094': {'bp': 673905.0, 'sum': 2440464.0}, '12_posi_7389': {'bp': 672693.0, 'sum': 2522444.0}, '6_posi_7307': {'bp': 648540.0, 'sum': 2490139.0}, '18_posi_7849': {'bp': 625679.0, 'sum': 2502700.0}, '15_posi_7706': {'bp': 593421.0, 'sum': 2349529.0}, 'BLK02_7475': {'bp': 543326.0, 'sum': 2074265.0}, '4_posi_7181': {'bp': 830367.0, 'sum': 3057000.0}, '12_posi_7144': {'bp': 810852.0, 'sum': 3014806.0}, '4_posi_7349': {'bp': 729624.0, 'sum': 2753956.0}, '14_posi_7601': {'bp': 699900.0, 'sum': 2612326.0}, '19_posi_7116': {'bp': 643373.0, 'sum': 2512215.0}, '18_posi_7431': {'bp': 639861.0, 'sum': 2457949.0}, '6_posi_7495': {'bp': 581026.0, 'sum': 2228451.0}, '5_posi_7221': {'bp': 671594.0, 'sum': 2540461.0}, '17_posi_7034': {'bp': 656569.0, 'sum': 2576269.0}, '18_posi_7577': {'bp': 654697.0, 'sum': 2470824.0}, 'BLK02_7159': {'bp': 615401.0, 'sum': 2283355.0}, 'ProcedureBlank_7370': {'bp': 719843.0, 'sum': 2672415.0}, '18_posi_7074': {'bp': 705282.0, 'sum': 2617479.0}, '4_posi_7454': {'bp': 581272.0, 'sum': 2280817.0}, '5_posi_7032': {'bp': 688629.0, 'sum': 2365282.0}, 'ProcedureBlank_7013': {'bp': 696489.0, 'sum': 2527588.0}}
COMMENT: RETENTION_TIME_STDEV 0.522
COMMENT: PRECURSOR_M/Z_RAW 214.154617
COMMENT: PRECURSOR_M/Z_STDEV 0.000061
COMMENT: PRECURSOR_IN_MS1 mz 214.154994; int 169.992; delta(ppm) 1.092390
COMMENT: PROPOSED_CHARGE_STATE +1; mz 215.158307; int 17.770; cor 0.657
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+CH3OH+H; M+NH4; mz 199.155367; int 77.129; cor 0.637
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.056; C10H19N3O2; [M+H]+; delta(ppm) -0.056299
COMMENT: PROPOSED_MF SevenGoldenRules 0.055; C9H15N3O; [M+CH3OH+H]+; delta(ppm) -0.055212
COMMENT: PROPOSED_MF MS-FINDER 3.407; C10H19N3O2; [M+H]+; delta(ppm) -0.057455
COMMENT: PROPOSED_MF MS-FINDER 3.121; C9H15N3O; [M+CH3OH+H]+; delta(ppm) -0.057455
COMMENT: PROPOSED_MF SIRIUS5_Sirius 54.610; C10H19N3O2; [M+H]+; delta(ppm) -0.057455
COMMENT: PROPOSED_MF SIRIUS5_Sirius 24.771; C9H15N3O; [M+CH4O+H]+; delta(ppm) -0.057455
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H15N3O; [M+CH4O+H]+; delta(ppm) -0.057455
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H19N3O2; [M+H]+; delta(ppm) -0.057455
COMMENT: PROPOSED_MF SIRIUS6_Sirius 99.506; C10H19N3O2; [M+H]+; delta(ppm) -0.057455
COMMENT: PROPOSED_MF SIRIUS6_Sirius 99.506; C9H15N3O; [M+CH4O+H]+; delta(ppm) -0.057455
COMMENT: PROPOSED_MF SIRIUS6_Sirius 51.119; C6H16FN3O2; [M+CH4O+H]+; delta(ppm) -5.393065
COMMENT: PROPOSED_MF SIRIUS6_Sirius 50.931; C4H14FN6O; [M+CH4O+H]+; delta(ppm) 0.876494
COMMENT: PROPOSED_MF SIRIUS6_Sirius 44.643; C8H17N6O; [M+H]+; delta(ppm) 6.212172
COMMENT: PROPOSED_MF SIRIUS6_Sirius 44.643; C7H13N6; [M+CH4O+H]+; delta(ppm) 6.212172
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.272; C5H18N4OP; [M+CH4O+H]+; delta(ppm) -1.500814
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.524; C12H21O3; [M+H]+; delta(ppm) -6.327003
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.524; C11H17O2; [M+CH4O+H]+; delta(ppm) -6.327003
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.957; C3H16N7P; [M+CH4O+H]+; delta(ppm) 4.768795
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.300; C4H17N6S; [M+CH4O+H]+; delta(ppm) -9.529307
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H19N3O2; [M+H]+; delta(ppm) -0.057455
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H15N3O; [M+CH4O+H]+; delta(ppm) -0.057455
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.693; ILBQBCDZPWYQPS-UHFFFAOYSA-N; [M+H]+; UNPD35190
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.426; HPBNRIOWIXYZFK-UHFFFAOYSA-N; [M+H]+; Guanadrel Sulfate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.276; JVPFKVWSCCAXMM-UHFFFAOYSA-N; [M+H]+; 2-(2-methoxyethyl)-7-methyl-octahydroimidazo[1,5-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.224; AGVCUVJROUBIKP-HGXVMFPFNA-N; [M+H]+; UNPD165572
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.000; NQCPECCCWDWTJJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-diethylamino-6-methylpyrimidin-4(1H)-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.835; ZNXAJGZPUQOEDZ-UHFFFAOYSA-N; [M+CH3OH+H]+; 6-ethyl-4,5,7,8-tetrahydro-[1,3]oxazolo[4,5-d]azepin-2-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.821; ZIJBPFPFSGVPTO-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-amino-6-(3-methylbutyl)-3,4-dihydropyrimidin-4-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.806; PGZWFWGPWUBXAZ-QMMMGPOBSA-N; [M+CH3OH+H]+; (2S)-N-(cyanomethyl)-1-ethylpyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.704; MGESDKOHGQHZFN-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-(aminomethyl)-4-(methoxymethyl)-2-methylpyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ILBQBCDZPWYQPS-UHFFFAOYSA-N; [M+H]+; UNPD35190
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ZIJBPFPFSGVPTO-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-amino-6-(3-methylbutyl)-3,4-dihydropyrimidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.955; JVPFKVWSCCAXMM-UHFFFAOYSA-N; [M+H]+; 2-(2-methoxyethyl)-7-methyl-octahydroimidazo[1,5-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.861; ZNXAJGZPUQOEDZ-UHFFFAOYSA-N; [M+CH3OH+H]+; 6-ethyl-4,5,7,8-tetrahydro-[1,3]oxazolo[4,5-d]azepin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.610; HPBNRIOWIXYZFK-UHFFFAOYSA-N; [M+H]+; Guanadrel Sulfate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.526; AGVCUVJROUBIKP-HGXVMFPFNA-N; [M+H]+; UNPD165572
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.523; MGESDKOHGQHZFN-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-(aminomethyl)-4-(methoxymethyl)-2-methylpyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.484; NQCPECCCWDWTJJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-diethylamino-6-methylpyrimidin-4(1H)-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.292; PGZWFWGPWUBXAZ-QMMMGPOBSA-N; [M+CH3OH+H]+; (2S)-N-(cyanomethyl)-1-ethylpyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.578; HPBNRIOWIXYZFK-UHFFFAOYSA-N; [M+H]+; 2-(1,4-dioxaspiro[4.5]decan-3-ylmethyl)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.271; ZNXAJGZPUQOEDZ-UHFFFAOYSA-N; [M+CH3OH+H]+; 6-ethyl-4,5,7,8-tetrahydro-[1,3]oxazolo[4,5-d]azepin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.459; NQCPECCCWDWTJJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(diethylamino)-4-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.430; VYCNDBQWMCGZAA-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-amino-5-butyl-4-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.429; LISKJKUMLVQGKE-UHFFFAOYSA-N; [M+H]+; 1-morpholin-4-yl-2-piperazin-1-ylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.253; HSCWDVRVHYGIFA-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-amino-1-[2-(dimethylamino)ethyl]pyridin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.141; XIUNZPPHCCROJV-UHFFFAOYSA-N; [M+H]+; 2-morpholin-4-yl-1-piperazin-1-ylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.040; HPYAUWCUNUYIDG-UHFFFAOYSA-N; [M+H]+; 4-piperazin-1-ylpiperidine-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.904; HGZOYFLXLKNJHY-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-[2-(2-oxopyrrolidin-1-yl)ethylamino]propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.869; CQTKVYHURMMRPR-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(2-pyrrolidin-2-ylpropyl)-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.862; VINYJNGGVYOFMO-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-[2-(dimethylamino)ethoxy]pyridin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.808; DWMYGDSJFUBVKQ-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-methyl-5-(oxan-4-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.777; UIVPKOOMHSYUNJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-methyl-3-(piperidin-3-ylmethyl)-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.767; VPIPHCYJMTYWDB-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-methyl-1-(oxan-4-yl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.765; GMHNKGPHJQRSMQ-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-methyl-1-(oxan-4-yl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.762; XPNWLCXGUBWJGX-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-methyl-5-(4-methylpiperidin-4-yl)-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.761; SFUBOCVBYZCIFG-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-methyl-2-(oxan-4-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.745; ALMLRHBBDXINTB-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-methyl-4-(piperazin-1-ylmethyl)-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.734; VBBBTQSQJTVDDF-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-methyl-5-(oxan-4-yl)-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.734; FNHCEZVALREEJW-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-methyl-5-(oxan-4-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.726; GXYDRMDRTXLIHI-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-(aminomethyl)-3,4-diethyl-1H-pyridazin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.719; BIOMFDHHARGJFB-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-(3-methyl-1,2,4-oxadiazol-5-yl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.718; YONREVWIEOKSMK-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-(azepan-2-yl)-5-methyl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.704; IVCVUYGTIKYXFG-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-[4-(oxolan-3-yl)pyrazol-1-yl]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.691; ZCUQKBLYCPKOJS-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-carbamimidoylpyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; HHJDARBBDLVPJM-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-N-(2-methoxyethyl)-5-N-methylpyridine-2,5-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; XXIODYOSZOJCLL-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-ethyl-5-piperidin-3-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; BDYRHACUFFMVPT-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-methyliminopiperazine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.663; KIJUVFXYFIUKHM-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-propyl-6,7-dihydro-4H-pyrano[3,4-d]imidazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.638; UHKUQSBZFWWHQL-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(2-amino-3-methylbutanoyl)azetidine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.621; HCBVNRIFWSZMKU-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(4-amino-4,5,6,7-tetrahydroindazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.617; MUWLMGYRXAWPAY-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-(3-ethyl-1,2,4-oxadiazol-5-yl)cyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.602; QSCAGDQZSRZPOH-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-methyl-N-(oxan-4-yl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.598; DQENLXHRPLSILC-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-amino-5-pentyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.597; OOFRPEDNTOJVQY-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-(3,5-dimethyl-1H-pyrazol-4-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.591; GZIQHUCQRGBGBE-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-[(4-aminopyridin-2-yl)amino]-2-methylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.582; RYNLBXYARMGYPC-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-amino-5-butyl-2-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.568; KDHIXBKIBCKZQU-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-(1-methylimidazol-2-yl)piperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.563; BZFBHNLGVKEULM-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(1-methylimidazol-2-yl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.547; VWQGOQSMLIKZKR-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(5-methyl-1,2,4-oxadiazol-3-yl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.541; VNTQVHBPLVELRW-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(4-ethyl-1H-pyrazol-5-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.540; FSYSYUOZJAUBEU-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(2-methylpyrazol-3-yl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.537; JTINBOGNUWUGGZ-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-ethyl-3-piperidin-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.536; GQUXEPBUPCLZTC-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(2-methoxyethyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.530; RFHQJLOTULCXTL-IONNQARKSA-N; [M+CH3OH+H]+; [(2R,3S)-2-(2-methylpyrazol-3-yl)oxolan-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.525; IMEFHYRQGSBUQA-BDAKNGLRSA-N; [M+CH3OH+H]+; (2S,3R)-2-(1,5-dimethylpyrazol-4-yl)oxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.521; QZKNQIWHWNZUPG-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-methyl-2-(1-methylpyrazol-4-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.514; WKTDGUSTKNDUEI-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-propan-2-yl-3-pyrrolidin-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.503; QXNSDFXNTPPPMD-JGVFFNPUSA-N; [M+CH3OH+H]+; [(3S,4S)-4-(3-methylimidazol-4-yl)pyrrolidin-3-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.485; LUJBSCAJUSLCOU-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(1-methylpyrazol-4-yl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.483; UROOQQFWCQYSFT-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(3-methylimidazol-4-yl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.441; JRAVVMHGQVQNIQ-UHFFFAOYSA-N; [M+CH3OH+H]+; [2-(oxan-2-yl)pyrazol-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.438; DFXAYHVELVUPEU-UHFFFAOYSA-N; [M+H]+; N'-hydroxy-3-(3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)propanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.438; FNUWNALPTXNSAZ-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-cyclopentyloxy-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.429; YPJOOPMYFLEHFQ-UHFFFAOYSA-N; [M+CH3OH+H]+; [2-(1-methylpyrazol-4-yl)oxolan-2-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.409; SGVSDXUFVJGQOJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 1H-imidazol-2-yl(piperidin-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.394; KBRISCUGMBXEQV-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-(1-methylpyrazol-4-yl)piperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.353; HMELYHQGWKUPAH-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-(2-methylpyrazol-3-yl)piperidin-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -152.183; RYNLBXYARMGYPC; [M+CH4O+H]+; 6-Amino-5-butyl-2-methyl-4-pyrimidinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.327; ZIJBPFPFSGVPTO; [M+CH4O+H]+; 2-amino-6-(3-methylbutyl)-3H-pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -200.681; BONXRRQYFQOESU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -201.513; LISKJKUMLVQGKE; [M+H]+; piperazinoacetic acid-morpholide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.120; NQCPECCCWDWTJJ; [M+CH4O+H]+; 2-(diethylamino)-6-methylpyrimidin-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.649; JVPFKVWSCCAXMM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -220.423; GQUXEPBUPCLZTC; [M+CH4O+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -233.940; GMHNKGPHJQRSMQ; [M+CH4O+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -240.374; FNHCEZVALREEJW; [M+CH4O+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -241.511; DQENLXHRPLSILC; [M+CH4O+H]+; 6-Amino-5-pentyl-4-pyrimidinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.310; ILBQBCDZPWYQPS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.614; AGVCUVJROUBIKP; [M+H]+; L-valyl-L-prolinamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -266.699; CQTKVYHURMMRPR; [M+CH4O+H]+; 2-(2-pyrrolidin-2-ylpropyl)-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -266.993; MGESDKOHGQHZFN; [M+CH4O+H]+; Oprea1_123356
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -301.885; OEDOITYEASREQH; [M+H]+; 4-Morpholin-4-ylpiperidine-4-amide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -326.895; ZNXAJGZPUQOEDZ; [M+CH4O+H]+; Azepexol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -407.606; HPBNRIOWIXYZFK; [M+H]+; Hylorel
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.061; RYNLBXYARMGYPC; [M+CH4O+H]+; 6-Amino-5-butyl-2-methyl-4-pyrimidinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.044; BONXRRQYFQOESU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -150.108; LISKJKUMLVQGKE; [M+H]+; 1-(Morpholinocarbonylmethyl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -170.627; ZIJBPFPFSGVPTO; [M+CH4O+H]+; 2-amino-6-(3-methylbutyl)-3,4-dihydropyrimidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -180.097; VYCNDBQWMCGZAA; [M+CH4O+H]+; 2-Amino-5-butyl-6-methylpyrimidin-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -201.782; JVPFKVWSCCAXMM; [M+H]+; 2-(2-methoxyethyl)-7-methyl-octahydroimidazo[1,5-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -202.088; BONXRRQYFQOESU; [M+H]+; 4-[[N'-(3-methylbut-2-enyl)carbamimidoyl]amino]butanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -202.962; RYNLBXYARMGYPC; [M+CH4O+H]+; 4-Pyrimidinol, 6-amino-5-butyl-2-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -204.731; ILBQBCDZPWYQPS; [M+H]+; 4-[N-(3-methylbut-2-en-1-yl)carbamimidamido]butanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -210.856; MUWLMGYRXAWPAY; [M+CH4O+H]+; 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)cyclopentanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -221.441; NQCPECCCWDWTJJ; [M+CH4O+H]+; 2-(Diethylamino)-6-methyl-1H-pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -241.079; JUSNBVJTFYDFKR; [M+H]+; (2S)-2-amino-5-(1-aminopent-3-enylideneamino)pentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -252.334; CIYWWIHMEYBDFA; [M+H]+; N5-(1-iminopent-3-enyl)-L-ornithine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -256.871; GQUXEPBUPCLZTC; [M+CH4O+H]+; 1-(2-methoxyethyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -274.611; UHKUQSBZFWWHQL; [M+CH4O+H]+; 1-[(2S)-2-amino-3-methylbutanoyl]azetidine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -276.590; DQENLXHRPLSILC; [M+CH4O+H]+; 4-Pyrimidinol, 6-amino-5-pentyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -282.394; ZNXAJGZPUQOEDZ; [M+CH4O+H]+; Azepexole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -285.389; HHJDARBBDLVPJM; [M+CH4O+H]+; N5-(2-methoxyethyl)-N5-methylpyridine-2,5-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -328.994; VIABFASHQHHYNB; [M+H]+; 2-(Hydroxyimino)-N-(2-(azepan-1-yl)ethyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -358.509; OEDOITYEASREQH; [M+H]+; 4-Morpholin-4-ium-4-ylpiperidin-1-ium-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -376.155; NOBVHVGPMMOHAE; [M+H]+; 1-[(2S)-2-aminopentanoyl]pyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -378.561; AGVCUVJROUBIKP; [M+H]+; 1-(2-amino-3-methylbutanoyl)pyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.307; LISKJKUMLVQGKE; [M+H]+; 1-(Morpholinocarbonylmethyl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.055; ZIJBPFPFSGVPTO; [M+CH4O+H]+; 2-amino-6-(3-methylbutyl)-3,4-dihydropyrimidin-4-one
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C10H20N3O2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 14.833
MS$FOCUSED_ION: PRECURSOR_M/Z 214.154991
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-1890000000-f5e4064f455b08ae96d4
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  68.0494290 10.9437 68.050060 1.4401 2.83 0.3862 131 f{C4H6N1}/-0.68ppm,p-C6H14N2O2
  83.0603463 59.7531 83.060850 0.7344 6.06 0.6600 135 f{C4H7N2}/-0.34ppm,p-C6H13N1O2
  85.0760208 51.5175 85.076500 0.8110 6.08 0.5635 135 f{C4H9N2}/-0.05ppm,p-C6H11N1O2
  86.0599633 12.1222 86.060430 1.7430 3.12 0.3367 132 f{C4H8N1O1}/-0.89ppm,p-C6H12N2O1
  86.0963588 8.5933 86.096825 1.8468 1.85 0.3453 102 f{C5H12N1}/-0.78ppm,p-C5H8N2O2
  87.0916869 56.7652 87.092140 0.7808 6.61 0.5103 135 f{C4H11N2}/0.14ppm,p-C6H9N1O2
  97.0760250 12.7896 97.076370 1.4422 3.03 0.2879 133 f{C5H9N2}/0.00ppm,p-C5H11N1O2
  111.0916844 428.4221 111.091900 0.2700 23.44 0.8205 135 f{C6H11N2}/0.09ppm,p-C4H9N1O2
  112.0756602 9.7476 112.075865 2.2842 2.43 0.2744 106 f{C6H10N1O1}/-0.27ppm,p-C4H10N2O1
  113.1073368 144.7945 113.107530 0.4332 10.93 0.6589 135 f{C6H13N2}/0.11ppm,p-C4H7N1O2
  126.1026432 43.5714 126.102670 1.2688 7.21 0.4226 135 f{C6H12N3}/0.55ppm,p-C4H8O2
  127.1104778 38.5105 127.110490 1.3768 6.16 0.4944 135 f{C6H13N3}/0.62ppm,p-C4H7O2
  128.1183025 89.3653 128.118300 0.7259 7.71 0.6256 135 f{C6H14N3}/0.61ppm,p-C4H6O2
  130.0863020 97.3800 130.086270 0.6150 10.16 0.6750 135 f{C6H12N1O2}/0.36ppm,p-C4H8N2
  130.1339128 400.7888 130.133880 0.2766 30.81 0.6968 135 f{C6H16N3}/0.30ppm,p-C4H4O2
  140.1182758 10.7725 140.118180 2.1625 2.70 0.3939 123 f{C7H14N3}/0.37ppm,p-C3H6O2
  141.0004163 47.7732 141.000320 1.3333 8.60 0.5238 135 ?
  154.1339248 28.6717 154.133820 1.4857 6.01 0.3774 135 f{C8H16N3}/0.33ppm,p-C2H4O2
  158.0270573 61.3733 158.026950 0.9745 11.94 0.3517 135 ?
  169.0971344 65.7213 169.097020 0.9817 8.59 0.7007 135 f{C8H13N2O2}/-0.12ppm,p-C2H7N1
  170.1050851 18.4074 170.104970 1.6754 4.29 0.4221 135 f{C8H14N2O2}/0.62ppm,p-C2H6N1
  170.1652451 29.9423 170.165130 1.6220 5.12 0.4241 135 f{C9H20N3}/0.42ppm,p-C1O2
  196.1636415 18.9925 196.163510 2.0289 3.83 0.2732 129 ?
  197.1285321 14.4398 197.128400 2.0900 3.81 0.2478 134 f{C10H17N2O2}/0.40ppm,p-H3N1
  197.1761621 109.7415 197.176030 0.7506 9.04 0.6196 135 ?
  214.1201976 34.7771 214.120055 1.8588 8.17 0.1991 134 ?
  214.1552527 776.2613 214.155110 0.3642 54.62 1.0000 135 f{C10H20N3O2}/1.16ppm,p
  214.2025227 999.0000 214.202380 0.3221 0.00 0.7829 135 ?
PK$NUM_PEAK: 28
PK$PEAK: m/z int. rel.int.
  68.049429 10.94 10
  83.060346 59.75 59
  85.076021 51.52 51
  86.059963 12.12 12
  86.096359 8.59 8
  87.091687 56.77 56
  97.076025 12.79 12
  111.091684 428.42 428
  112.075660 9.75 9
  113.107337 144.79 144
  126.102643 43.57 43
  127.110478 38.51 38
  128.118303 89.37 89
  130.086302 97.38 97
  130.133913 400.79 400
  140.118276 10.77 10
  141.000416 47.77 47
  154.133925 28.67 28
  158.027057 61.37 61
  169.097134 65.72 65
  170.105085 18.41 18
  170.165245 29.94 29
  196.163641 18.99 18
  197.128532 14.44 14
  197.176162 109.74 109
  214.120198 34.78 34
  214.155253 776.26 776
  214.202523 999.00 999
//
